Evidence map›Paper›PMID 38090131›Full record

ArticleACS materials Au2023

Synthesis of Antimicrobial Gallium Nanoparticles Using the Hot Injection Method.

Christina Limantoro, Theerthankar Das, Meng He, Dmitry Dirin, Jim Manos, Maksym V Kovalenko, Wojciech Chrzanowski

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS materials Au, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Solution-Phase Design of Emerging Nanomaterials.Chemistry of materials : a publication of the American Chemical Society · 2025
    Review
  2. Fullerene Gallium Phosphonate Shows Antimycobacterial Effect AgainstInternational journal of molecular sciences · 2025
    Article
  3. Review
  4. Gallium Resistance inApplied microbiology (Basel, Switzerland) · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Christina LimantoroSydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.
Theerthankar DasDepartment of Infectious Diseases and Immunology, School of Medical Sciences, The University of Sydney, Camperdown, NSW 2006, Australia.ORCID https://orcid.org/0000-0003-0581-6060
Meng HeDepartment of Chemistry and Applied Biosciences, ETH Zürich-Swiss Federal Institute of Technology Zürich, Vladimir Prelog Weg 1, CH-8093 Zürich, Switzerland.
Dmitry DirinDepartment of Chemistry and Applied Biosciences, ETH Zürich-Swiss Federal Institute of Technology Zürich, Vladimir Prelog Weg 1, CH-8093 Zürich, Switzerland.
Jim ManosDepartment of Infectious Diseases and Immunology, School of Medical Sciences, The University of Sydney, Camperdown, NSW 2006, Australia.
Maksym V KovalenkoDepartment of Chemistry and Applied Biosciences, ETH Zürich-Swiss Federal Institute of Technology Zürich, Vladimir Prelog Weg 1, CH-8093 Zürich, Switzerland.ORCID https://orcid.org/0000-0002-6396-8938
Wojciech ChrzanowskiSydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.ORCID https://orcid.org/0000-0001-8050-8821
The University of Sydney · AUETH Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic resistance continues to be an ongoing problem in global public health despite interventions to reduce antibiotic overuse. Furthermore, it threatens to undo the achievements and progress of modern medicine. To address these issues, the development of new alternative treatments is needed. Metallic nanoparticles have become an increasingly attractive alternative due to their unique physicochemical properties that allow for different applications and their various mechanisms of action. In this study, gallium nanoparticles (Ga NPs) were tested against several clinical strains of

Identifiers

PMID38090131
PMCPMC10347687
OpenAlexW4361212846

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.